75887-71-7

Upstream product

• 7311-34-4 3,5-dimethoxybenzaldehdye 
• 75887-69-3 1-<3,5-Dimethoxybenzyl>-aethan-1,1,2-tricarbonsaeure-triaethylester 
• 70489-34-8 3-(3,5-dimethoxyphenyl)-1,2,2-propanetricarboxylic acid 
• 877-88-3 3,5-dimethoxybenzyl bromide 
• 66611-23-2 2-[1-(3,5-Dimethoxy-phenyl)-meth-(E)-ylidene]-succinic acid diethyl ester 
• 75887-70-6 2-(3,5-dimethoxyphenylmethyl)butandioic acid 

Downstream Products

• 220094-27-9 toluene-4-sulfonic acid 5,7-dimethoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl ester 
• 220094-28-0 C₂₂H₂₆O₅S₃ 
• 75887-75-1 2-<(carbobenzyloxy)amino>-5,7-dimethoxytetralin 
• 75903-09-2 2-(benzylamino)-5,7-dimethoxytetralin 

Relevant academic research and scientific papers

Synthesis of a tetracyclic, conformationally constrained analogue of Δ8-THC

A tetracyclic, conformationally constrained analogue of Δ8-THC (2) has been synthesized in which a two carbon bridge exists between C2 and C2'. Two conceptually related syntheses of 2 are described, both of which employ 5,7-dimethoxy-4-oxo-1,2,

5,7-Dihydroxy-2-aminotetralin Derivatives: Synthesis ans Assessment of Dopaminergic and Adrenergic Actions

Replacement of the catechol 3,4-dihydroxylation pattern of certain adrenergic β-phenethylamines by a resorcinol 3,5-dihydroxylation pattern has led to greater selectivity of adrenergic agonist effects in certain molecules.This strategy has been applied to